FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion

被引:116
|
作者
Benlimame, N
He, Q
Jie, S
Xiao, DZ
Xu, YJ
Loignon, M
Schlaepfer, DD
Alaoui-Jamali, MA [1 ]
机构
[1] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ H3T 1E2, Canada
[3] Scripps Res Inst, La Jolla, CA 92037 USA
来源
JOURNAL OF CELL BIOLOGY | 2005年 / 171卷 / 03期
关键词
D O I
10.1083/jcb.200504124
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The overexpression of members of the ErbB tyrosine kinase receptor family has been associated with cancer progression. We demonstrate that focal adhesion kinase (FAK) is essential for oncogenic transformation and cell invasion that is induced by ErbB-2 and -3 receptor signaling. ErbB-2/3 overexpression in FAK-deficient cells fails to promote cell transformation and rescue chemotaxis deficiency. Restoration of FAK rescues both oncogenic transformation and invasion that is induced by ErbB-2/3 in vitro and in vivo. In contrast, the inhibition of FAK in FAK-proficient invasive cancer cells prevented cell invasion and metastasis formation. The activation of ErbB-2/3 regulates FAK phosphorylation at Tyr-397, -861, and -925. ErbB-induced oncogenic transformation correlates with the ability of FAK to restore ErbB-2/3-induced mitogen-activated protein kinase ( MAPK) activation; the inhibition of MAPK prevented oncogenic transformation. In contrast, the inhibition of Src but not MAPK prevented ErbB-FAK-induced chemotaxis. In migratory cells, activated ErbB-2/3 receptors colocalize with activated FAK at cell protrusions. This colocalization requires intact FAK. In summary, distinct FAK signaling has an essential function in ErbB-induced oncogenesis and invasiveness.
引用
收藏
页码:505 / 516
页数:12
相关论文
共 50 条
  • [31] Cooperative signaling between α6β4 integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion
    Gambaletta, D
    Marchetti, A
    Benedetti, L
    Mercurio, AM
    Sacchi, A
    Falcioni, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) : 10604 - 10610
  • [32] ONCOGENIC POTENTIAL OF ERBB-2 IN HUMAN MAMMARY EPITHELIAL-CELLS
    PIERCE, JH
    ARNSTEIN, P
    DIMARCO, E
    ARTRIP, J
    KRAUS, MH
    LONARDO, F
    DIFIORE, PP
    AARONSON, SA
    ONCOGENE, 1991, 6 (07) : 1189 - 1194
  • [33] Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia
    Black, Laurel E.
    Longo, Jody F.
    Carroll, Steven L.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (10): : 1898 - 1912
  • [34] The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands
    Tzahar, E
    Yarden, Y
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1377 (01): : M25 - M37
  • [35] The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands
    Tzahar, E.
    Yarden, Y.
    B B A - Biomembranes, 1377 (01):
  • [36] In vitro spontaneous transformation of rat BDEI cholangiocytes compared with oncogenic erbB-2/neu transformants.
    Sirica, A. E.
    Asano, T.
    Zhang, Z.
    Mahatme, A.
    Ward, D. J.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2007, 43 : S34 - S34
  • [37] EXTRACELLULAR PORTIONS OF EGF RECEPTOR WITH TGFa AND ErbB-2
    Garrett, P. J.
    Lou, M. Z.
    McKern, N. M.
    Adams, T. E.
    Lovrecz, G. O.
    Jorissen, R. N.
    Nice, E. C.
    Burgess, A. W.
    Ward, C. W.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C5 - C5
  • [38] Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer
    Siegel, PM
    Ryan, ED
    Cardiff, RD
    Muller, WJ
    EMBO JOURNAL, 1999, 18 (08): : 2149 - 2164
  • [39] Progesterone receptor and ErbB-2 crosstalk in breast cancer
    Beguelin, Wendy
    Flaque, Maria C. Diaz
    Cayrol, Florencia
    Proietti, Cecilia J.
    Rivas, Martin A.
    Tkach, Mercedes
    Charreau, Eduardo H.
    Schillaci, Roxana
    Elizalde, Patricia V.
    CANCER RESEARCH, 2010, 70
  • [40] An ErbB-3 Antibody, MP-RM-1, Inhibits Tumour Growth by Blocking Ligand-dependent and Independent Activation of ErbB-3/Akt Signaling
    Iacobelli, S.
    Sala, G.
    Traini, S.
    D'Egidio, M.
    Di Risio, A.
    Tinari, N.
    Natali, P. G.
    Muraro, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S152 - S152